Edition:
United Kingdom

PLx Pharma Inc (PLXP.OQ)

PLXP.OQ on NASDAQ Stock Exchange Capital Market

6.70USD
22 Feb 2018
Change (% chg)

$-0.05 (-0.74%)
Prev Close
$6.75
Open
$6.70
Day's High
$6.80
Day's Low
$6.65
Volume
2,782
Avg. Vol
4,844
52-wk High
$12.60
52-wk Low
$5.60

Chart for

About

PLx Pharma Inc., formerly Dipexium Pharmaceuticals, Inc., is a biopharmaceutical company. The Company is a late stage specialty pharmaceutical company focusing on commercializing its lead products: Aspertec 325 mg and Aspertec 81 mg (Aspertec). The Company’s products and technology includes PLxGuard delivery system, Aspertec 325... (more)

Overall

Beta: 1.85
Market Cap(Mil.): $55.17
Shares Outstanding(Mil.): 8.69
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 83.93 16.60
EPS (TTM): -- -- --
ROI: -- 1.66 10.66
ROE: -- 2.58 14.30

BRIEF-Park West Asset Management reports 12.3 pct stake in PLx Pharma

* Park West Asset Management Llc reports 12.3 percent stake in PLx Pharma Inc ‍​as of November 20 - SEC filing

20 Nov 2017

BRIEF-PLx Pharma Inc. Reports third quarter 2017 results

* Q3 loss per share $0.44 Source text for Eikon: Further company coverage:

09 Nov 2017

Earnings vs. Estimates